Oncology Clinical Drug Developers 2021, is designed to identify clinical stage drug developer’s technologies, Management expertise, Funding and Partnering capabilities. It clearly demark individual company’s clinical pipeline and its emerging early stage oncology research pipeline. 

Report clearly puts top 50 large pharma companies oncology pipeline with mid and small size innovation driven pharma companies, and thus provides clear M&A target companies/molecules landscape. The Report covers 178 companies from Chinese region, thus provide an update on the emergence of this region in Oncology Drug Discovery.